New “First” Program: Six Months of Free Lab Space for Eligible First-Time Biotech Founders >

Press Releases

Aquinnah Pharmaceuticals Receives $3.4M Grant from NINDS To Advance New Therapies for ALS

June 20, 2018 | By

Share :